Everolimus in advanced/metastatic renal cell carcinoma in adults after sunitinib progression

被引：0
|
作者：
Martin-Vila, A. [1 ]
Alvarez-Payero, M. [1 ]
Martinez-Lopez de Castro, N. [1 ]
Suarez-Santamaria, M. [1 ]
Castro-Dominguez, J. M. [1 ]
Ascunce-Saldana, M. D. P. [1 ]
机构：
[1] Hosp Meixoeiro, Complexo Hosp Univ Vigo, Vigo, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2013年 / 35卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：907 / 907
页数：1
相关论文
共 50 条
  • [21] Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
    Mejean, A.
    Ravaud, A.
    Thezenas, S.
    Colas, S.
    Beauval, J. -B.
    Bensalah, K.
    Geoffrois, L.
    Thiery-Vuillemin, A.
    Cormier, L.
    Lang, H.
    Guy, L.
    Gravis, G.
    Rolland, F.
    Linassier, C.
    Lechevallier, E.
    Beisland, C.
    Aitchison, M.
    Oudard, S.
    Patard, J. -J.
    Theodore, C.
    Chevreau, C.
    Laguerre, B.
    Hubert, J.
    Gross-Goupil, M.
    Bernhard, J. -C.
    Albiges, L.
    Timsit, M. -O.
    Lebret, T.
    Escudier, B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (05): : 417 - 427
  • [22] Sunitinib in the treatment of metastatic renal cell carcinoma
    Schmid, Thomas A.
    Gore, Martin E.
    THERAPEUTIC ADVANCES IN UROLOGY, 2016, 8 (06) : 348 - 371
  • [23] Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma.
    Herrmann, E.
    Marschner, N.
    Grimm, M.
    Ohlmann, C. H.
    Hutzschenreuther, U.
    Overkamp, F.
    Groschek, M.
    Blumenstengel, K.
    Steiner, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [24] Sunitinib in patients with metastatic renal cell carcinoma
    Motzer, Robert J.
    Rini, Brian I.
    Bukowski, Ronald M.
    Curti, Brendan D.
    George, Daniel J.
    Hudes, Gary R.
    Redman, Bruce G.
    Margolin, Kim A.
    Merchan, Jaime R.
    Wilding, George
    Ginsberg, Michelle S.
    Bacik, Jennifer
    Kim, Sindy T.
    Baum, Charles M.
    Michaelson, M. Dror
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21): : 2516 - 2524
  • [25] Sunitinib for the treatment of metastatic renal cell carcinoma
    Oudard, Stephane
    Beuselinck, Benoit
    Decoene, Jasper
    Albers, Peter
    CANCER TREATMENT REVIEWS, 2011, 37 (03) : 178 - 184
  • [26] Intermittent sunitinib for metastatic renal cell carcinoma
    Venkatesan, Priya
    LANCET ONCOLOGY, 2017, 18 (03): : E139 - E139
  • [27] Recommendations on managing lenvatinib and everolimus in patients with advanced or metastatic renal cell carcinoma
    Grande, E.
    Glen, H.
    Aller, J.
    Argenziano, G.
    Lamas, M. J.
    Ruszniewski, P.
    Zamorano, J. L.
    Edmonds, K.
    Sarker, S.
    Staehler, M.
    Larkin, J.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (12) : 1413 - 1426
  • [28] Everolimus in metastatic renal cell cancer after sunitinib/sorafenib: a new standard for kidney cancer
    Massard, Christophe
    Bay, Jacques-Olivier
    BULLETIN DU CANCER, 2009, 96 (03) : 256 - 256
  • [29] Sequential treatment of metastatic Renal cell carcinoma Everolimus in Therapy of metastatic Renal cell carcinoma
    Gschwend, Juergen E.
    AKTUELLE UROLOGIE, 2011, 42 (03) : A4 - A5
  • [30] Economic Evaluation of Everolimus versus Sorafenib for the Treatment of Metastatic Renal Cell Carcinoma after Failure of First-Line Sunitinib
    Casciano, Roman
    Chulikavit, Maruit
    Di Lorenzo, Giuseppe
    Liu, Zhimei
    Baladi, Jean-Francois
    Wang, Xufang
    Robertson, Justin
    Garrison, Lou
    VALUE IN HEALTH, 2011, 14 (06) : 846 - 851
12345